Get the Stockscreener App
0.87
0.00%
0.00
Dyadic International Inc De stock is traded at $0.87, with a volume of 7,094.
It is up +0.00% in the last 24 hours and up +14.47% over the past month.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$0.87
Open:
$0.88
24h Volume:
7,094
Relative Volume:
0.11
Market Cap:
$32.06M
Revenue:
$3.09M
Net Income/Loss:
$-7.36M
P/E Ratio:
-3.8158
EPS:
-0.228
Net Cash Flow:
$-5.70M
1W Performance:
-2.54%
1M Performance:
+14.47%
6M Performance:
-15.53%
1Y Performance:
-29.27%
1-Day Range:
$0.87
$0.88
1-Week Range:
$0.801
$0.9389
52-Week Range:
$0.6546
$1.346
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.85 | 2.55B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
19.87 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.60 | 356.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
5.69 | 315.27M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
46.05 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Resumed | H.C. Wainwright | Buy |
| Sep-08-25 | Initiated | Craig Hallum | Buy |
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS
Dyadic International Earnings Call Highlights Commercial Pivot - TipRanks
Analysts Expect Breakeven For Dyadic International, Inc. (NASDAQ:DYAI) Before Long - Yahoo Finance
Dyadic International Q4 2025 Earnings Call Transcript - MarketBeat
Dyadic Applied BioSolutions: Innovative Microbial Protein Production Platforms for Life Sciences, Food, and Industrial Markets - Minichart
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ... By GuruFocus - ca.investing.com
Dyadic International’s ability to sustain operations for the next year and avoid significant dilution depends on the effectiveness of its shift toward commercial strategies - Bitget
Dyadic (DYAI) Q4 2025 Earnings Call Transcript - theglobeandmail.com
Earnings call transcript: Dyadic Q4 2025 reveals revenue decline, stock up 3.32% - Investing.com Australia
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress - Yahoo Finance Singapore
Dyadic (NASDAQ: DYAI) posts lower 2025 revenue and wider annual net loss - Stock Titan
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - The Manila Times
Dyadic to detail full-year 2025 results in March 25 investor call - Stock Titan
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - The Globe and Mail
Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free) - Yahoo Finance
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Alpha-Amylase Market Forecast Points Higher Toward 2035 Amid Sustainable Industrial ShiftNews and Statistics - IndexBox
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - Yahoo Finance
Segmentation, Major Trends, and Competitive Overview of the Industrial Biocatalysts Market - openPR.com
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World
Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World
Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World
iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star
Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire
Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com
Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins - Yahoo Finance
Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Finviz
Earnings call transcript: Dyadic’s Q3 2025 results miss forecasts, stock dips - Investing.com
Earnings call transcript: Dyadic's Q3 2025 results miss forecasts, stock dips - Investing.com UK
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.72%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):